跳至主要内容
临床试验/JPRN-UMIN000019273
JPRN-UMIN000019273已完成未知

To investigate DPP-4 inhibitors type dependent effects on antifibrotic miRNA and biomarkers. - DPP-4 inhibitors and antifibrotic biomarkers.

Kanazawa Medical University0 个研究点目标入组 60 人开始时间: 2015年10月8日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Patient who have a history of allergy to Linagliptin or Sitagliptin. (2)Patients who have severe ketosis, diabetic coma, diabetic pre-coma, or type 1 diabetes (3)Patients who have severe infection, surgery, planned surgery, severe trauma. (4)Women who are pregnant, or possibility of pregnant, or wish to pregnant, or lactating. (5)Patients with transit disorder in the digestive tract or peptic ulcer and esophageal varix (this product may irritate affected area.) and patients whom physician judges as inappropriate (6)Patients with a predisposition to severe and habitual constipation (this product may exacerbate constipation) and patients whom physician judges as inappropriate (7)Patients who are considered unsuitable for inclusion by the attending physician.

研究者

相似试验